LabCompass

Patrick O. Monahan

Medicine · Indiana University

OpenAlex ORCID
Established · publishing since 1987Rising activity
Cancer survivorship and careGlobal Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionTesticular diseases and treatmentsCancer-related cognitive impairment studies

Publications

541

Citations

17,749

Est. group size

~1

Recurring co-author estimate

Active years

40

Publishing since 1987

Research summary
AI-generated

Patrick O. Monahan conducts research in medicine with a strong focus on cancer survivorship, particularly the long-term health effects of chemotherapy for testicular and other cancers, as well as cancer screening programs. Much of the work involves patient-reported outcomes, validated health questionnaires, and applied biostatistics, often supporting large clinical studies and collaborations across many medical fields.

Cancer survivorship and long-term treatment effectsCancer screening and early detectionPatient-reported outcomes and questionnaire validationMental and behavioral health measurementGlobal and community health studies

Publication activity has been steady and generally high over the past decade, averaging around 33 papers per year with some year-to-year fluctuation.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Funding
Public award records

Current awards run through August 2029 — about 3 years of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.

  • ActiveNIH P30CA082709through Aug 2029 · $174k awarded

    Biostatistics & Data Management Core

4 earlier awards
  • NIH R01AR064081Sep 2012 – Aug 2018 · $239k awarded

    Responsiveness and Clinical Validity of PROMIS Pain and Depression Measures

  • NIH R01AG043465Sep 2013 – May 2018 · $469k awarded

    Develop and Validate Tool to Monitor Patient Centered Outcomes Through Caregivers

  • NIH R03CA168351May 2012 – Apr 2016 · $75k awarded

    Estimating health utilities using QOL data among patients with gyn malignancies

  • NIH R03CA113099Sep 2004 – Aug 2007 · $60k awarded

    Improving Item Bias Detection in Cancer Control Scales

Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.

In context
Among 5,073 established Medicine PIs within our index
Citations: 17,749cohort median 2,525
h-index: 63cohort median 24
Publications / year (recent): 33.8cohort median 4.8

Typically publishes in teams of ~8 · 8% small-team papers (≤3 authors) · across 121 venues

Publication cadence
Publications per year over the last 10 years — averaging 33.8/year recently
2017: 28 publications172018: 29 publications182019: 41 publications192020: 30 publications202021: 20 publications212022: 26 publications222023: 58 publications58232024: 27 publications242025: 42 publications252026: 16 publications26
Collaborators per year
Distinct co-authors at Indiana University each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
2017: 8 collaborators at the same institution2018: 12 collaborators at the same institution2019: 11 collaborators at the same institution2020: 13 collaborators at the same institution2021: 11 collaborators at the same institution2022: 8 collaborators at the same institution2023: 3 collaborators at the same institution2024: 32 collaborators at the same institution2025: 8 collaborators at the same institution1719212325
Recent publications
Publishes in
  • Journal of Clinical Oncology×24
  • Science×18
  • PMC×12
  • Gastroenterology×9
  • Author eBooks×8
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Sep 1, 2026.

Claim or correct this profile